Attached files
| file | filename |
|---|---|
| 10-Q - VCYT - 10Q Q1 2020 - VERACYTE, INC. | vcyt-20200331.htm |
| EX-32.1 - VCYT - 10Q Q1 2020 EXHIBIT 32.1 - VERACYTE, INC. | vcyt-03312020xex321.htm |
| EX-31.2 - VCYT - 10Q Q1 2020 EXHIBIT 31.2 - VERACYTE, INC. | vcyt-03312020xex312.htm |
| EX-31.1 - VCYT - 10Q Q1 2020 EXHIBIT 31.1 - VERACYTE, INC. | vcyt-03312020xex311.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of Veracyte, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officer of the Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to such officer’s knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: | May 6, 2020 | |||||||
| /s/ Keith Kennedy | ||||||||
| Keith Kennedy | ||||||||
| Chief Operating Officer and Chief Financial Officer | ||||||||
| (Principal Financial Officer) | ||||||||
1